UCLA, Division of Surgical Oncology / Cancer Surgery Service
Reading Syllabus
Table of Contents
Breast Cancer
1) Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and
results after 12 years of follow-up in a randomized clinical trial comparing total
mastectomy with lumpectomy with or without irradiation in the treatment of breast
cancer. N Engl J Med. 1995 Nov 30;333(22):1456-61.
2) Morrow M, Schnitt SJ. Treatment selection in ductal carcinoma in situ. JAMA. 2000 Jan
26;283(4):453-5.
3) Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P,
Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized
comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl
J Med. 2003 Aug 7;349(6):546-53.
4) Pegram MD, Pienkowski T, Northfelt DW, Eiermann W, Patel R, Fumoleau P, Quan E, Crown J,
Toppmeyer D, Smylie M, Riva A, Blitz S, Press MF, Reese D, Lindsay MA, Slamon DJ. Results
of two open-label, multicenter phase II studies of docetaxel, platinum salts, and
trastuzumab in HER2-positive advanced breast cancer. J Natl Cancer Inst. 2004 May
19;96(10):759-69.
Colon / Rectal Cancer & Liver Metastases
1) Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J,
Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer
Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N
Engl J Med. 2004 Oct 21;351(17):1731-40.
2) Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C,
Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A; Multicenter International
Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer
(MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for
colon cancer. N Engl J Med. 2004 Jun 3;350(23):2343-51.
3) Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting
recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001
consecutive cases. Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21.
4) Veronese ML, O'Dwyer PJ. Monoclonal antibodies in the treatment of colorectal cancer. Eur
J Cancer. 2004 Jun;40(9):1292-301.
Gastric Cancer
1) Kooby DA, Coit DG. Controversies in the surgical management of gastric cancer. JNCCN.
2003 Jan;1(1):115-24.
2) Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG,
Ajani JA, Gunderson LL, Jessup JM, Martenson JA. Chemoradiotherapy after surgery
compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal
junction. N Engl J Med. 2001 Sep 6;345(10):725-30.
3) Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe
JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ,
MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable
gastroesophageal cancer. N Engl J Med. 2006 Jul 6;355(1):11-20.
Gastric Cancer
4) D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial
recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004 Nov;240(5):80816.
Melanoma
1) Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC,
Barnhill RL, Jewell WR, Wanebo HJ, Desmond R; Investigators from the Intergroup Melanoma
Surgical Trial. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm
excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 2001
Mar;8(2):101-8.
2) Kammula US, Ghossein R, Bhattacharya S, Coit DG. Serial follow-up and the prognostic
significance of reverse transcriptase-polymerase chain reaction - staged sentinel lymph
nodes from melanoma patients. J Clin Oncol. 2004 Oct 1;22(19):3989-96.
3) McMasters KM, Noyes RD, Reintgen DS, Goydos JS, Beitsch PD, Davidson BS, Sussman JJ,
Gershenwald JE, Ross MI; Sunbelt Melanoma Trial. Lessons learned from the Sunbelt
Melanoma Trial. J Surg Oncol. 2004 Jul 1;86(4):212-23.
4) Sabel MS, Sondak VK. Point: Interferon-α for adjuvant therapy for melanoma patients.
5) Chapman PB. Coutnerpoint: The case against adjuvant high-dose interferon-α for
melanoma patients. JNCCN. 2004 Jan;1(2):61-72.
Pancreatic Cancer
1) Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based
approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll
Surg. 2003 Jun;196(6):954-64.
2) Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy
after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 2003
May;185(5):476-80.
3) Todd KE, Gloor B, Lane JS, Isacoff WH, Reber HA. Resection of locally advanced pancreatic
cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C,
leucovorin, and dipyridamole. J Gastrointest Surg. 1998 Mar-Apr;2(2):159-66.
4) Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients
undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004 Aug;240(2):2938.
Soft Tissue Sarcoma
1) Eilber FC, Eilber FR, Eckardt J, Rosen G, Riedel E, Maki RG, Brennan MF, Singer S. The
impact of chemotherapy on the survival of patients with high-grade primary extremity
liposarcoma. Ann Surg. 2004 Oct;240(4):686-95; discussion 695-7.
2) Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M, Dorey F, Eilber FR.
Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in
patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J
Clin Oncol. 2001 Jul 1;19(13):3203-9.
3) Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P,
Buonadonna A, Pignatti G, Barbieri E, Apice G, Zmerly H, Serraino D, Picci P. Adjuvant
chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the
Italian randomized cooperative trial. J Clin Oncol. 2001 Mar 1;19(5):1238-47.
4) Eilber FC, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW. Validation of the
postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004 Oct
13;101(10):2270-75.
Palliative
1) Miner TJ, Brennan MF, Jaques DP. A prospective, symptom related, outcomes analysis of
1022 palliative procedures for advanced cancer. Ann Surg. 2004 Oct;240(4):719-26